Brief: PainReform Announces Phase 3 Clinical Trial Commencement To Evaluate PRF-110
14/03/2023 13:15
March 14 (Reuters) - PainReform Ltd PRFX.O :
* PAINREFORM ANNOUNCES COMMENCEMENT OF PHASE 3 CLINICAL
TRIAL TO
EVALUATE PRF-110 IN PATIENTS UNDERGOING BUNIONECTOMY SURGERY
Source text for Eikon: ID:nGNX1FTJbX
Further company coverage: PRFX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PRF Technologies
See all newsBrief: Prf Technologies S.H.N. Financial Investments Seeks Special General Meeting At Prf Technologies To Remove Directors, Appoint Three S.H.N. Nominees
U.S. STOCKS ON THE MOVE-Bumble, Tempus AI, TD Synnex
U.S. STOCKS ON THE MOVE-Bio-Techne, IBM, Apple
PRF Technologies rises as animal study shows pain drug matches approved rival
U.S. STOCKS ON THE MOVE-Wendy's, Canadian Solar, Bio-Techne